Progen Pharmaceuticals Limited (PGLA) 0.1600

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Progen Pharmaceuticals Limited (PGLA) 0.1600 $PGLA

Progen Pharma to acquire molecular diagnostics firm
Seeking Alpha - at Seeking Alpha - Fri May 01, 7:02AM CDT


Metastatic Melanoma - Pipeline Review, H1 2014
M2 - Thu Dec 18, 3:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/2pb9ww/metastatic) has announced the addition of the "Metastatic Melanoma - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Metastatic Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Melanoma and special features on late-stage and discontinued projects. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Metastatic Melanoma - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Metastatic Melanoma pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Bristol-Myers Squibb Company - F. Hoffmann-La Roche Ltd. - Vical Incorporated - Amgen Inc. - Sanofi - AstraZeneca PLC - GlaxoSmithKline plc - Genentech, Inc. - MedImmune, LLC - Plexxikon Inc. - Delcath Systems, Inc. - Millennium Pharmaceuticals, Inc. - Novartis AG - Eisai Co., Ltd. - Ono Pharmaceutical Co., Ltd. - Pfizer Inc. - Celgene Corporation - Bayer AG - Incyte Corporation - Luitpold Pharmaceuticals, Inc. - Merck KGaA - Celldex Therapeutics, Inc. - Momenta Pharmaceuticals, Inc. - AVAX Technologies, Inc. - Oncolytics Biotech Inc. - Antisoma plc - Progen Pharmaceuticals Limited - HanAll Biopharma Co., Ltd. - Provectus Biopharmaceuticals, Inc. - BioAlliance Pharma SA For more information visit http://www.researchandmarkets.com/research/2pb9ww/metastatic
ONCY: 0.58 (+0.03), PFE: 34.36 (+0.50), INCY: 108.33 (+0.22), CLDX: 24.89 (+0.42), AMGN: 154.10 (+2.79), BMY: 69.27 (+1.38), GSK: 42.45 (+0.65), MNTA: 21.76 (+0.49), PVCT: 0.51 (+0.01), VICL: 0.70 (unch), AZN: 66.45 (+1.90), DCTH: 0.84 (unch), NVS: 103.22 (+3.20), CELGZ: 2.15 (+0.14)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 35

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 19

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 47

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 31

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 26

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 29

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

ConocoPhillips Prepares for Third Quarter Earnings Report

Updated Category News Views 132

ConocoPhillips Earnings Preview ConocoPhillips (NYSE: COP) is set to unveil its earnings results for the third quarter, drawing significant attention from investors and analysts alike. This report is expected to be released before the opening bell on the designated Thursday. Analysts project that ConocoPhillips will report earnings of $1.41 per share, a decrease from...

Continue Reading
Tesla's FSD Ambitions Shine Amid Market Uncertainty

Updated Category News Views 138

Tesla's Ambitious Goals for Full Self-Driving Technology Tesla, Inc. TSLA is pursuing an ambitious plan to introduce its groundbreaking full self-driving (FSD) technology to markets around the world, with a particular focus on regions in Asia and Europe. What to Anticipate from Tesla's FSD Launch Industry expert Greg Migliore, editor-in-chief of Real Auto Blog, bel

Continue Reading
Centners Pursue $885M Defamation Case Against Local Newspaper

Updated Category News Views 230

Centners File Major Defamation Lawsuit Against a Newspaper Philanthropists and entrepreneurs David and Leila Centner have taken a significant step by initiating a defamation lawsuit against a prominent newspaper and several journalists. They are asserting that the newspaper has intentionally misrepresented public records regarding their generous donation intentions aimed...

Continue Reading
NACCO Industries Reports Solid Performance Amid Challenges

Updated Category News Views 140

NACCO Industries Announces Second Quarter Results NACCO Industries, Inc. (NYSE: NC) has revealed its consolidated results for the three and six months ending in June 2025. The company faced some short-term operational challenges, impacting their ability to meet expected growth targets. Despite this setback, NACCO's versatile sectors remain primed for recovery and...

Continue Reading
Unlocking Income: Earning $500 Monthly from Jefferies Stock

Updated Category News Views 100

Understanding Jefferies Financial Group Inc. Jefferies Financial Group Inc. (NYSE: JEF) is a key player in the financial services sector, known for its robust investment banking operations and diverse financial solutions. With the company's upcoming earnings report for the fourth quarter, there’s excitement surrounding its performance and future potential. Although the...

Continue Reading